home All News open_in_new Full Article

Production of cheaper alternatives to name brand obesity drugs will stop on Wednesday

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.


today 2 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3962436359
Add Watch Country

arrow_drop_down